Jazz Pharmaceuticals Plc (JAZZ)
245.71
+5.23
(+2.17%)
USD |
NASDAQ |
Sep 11, 16:00
245.71
0.00 (0.00%)
After-Hours: 16:25
Jazz Pharmaceuticals Gross Profit (TTM) : 3.388B for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.388B |
| March 31, 2026 | 3.233B |
| December 31, 2025 | 3.110B |
| September 30, 2025 | 3.036B |
| June 30, 2025 | 2.993B |
| March 31, 2025 | 2.984B |
| December 31, 2024 | 2.996B |
| September 30, 2024 | 2.949B |
| June 30, 2024 | 2.878B |
| March 31, 2024 | 2.827B |
| December 31, 2023 | 2.790B |
| September 30, 2023 | 2.705B |
| June 30, 2023 | 2.655B |
| March 31, 2023 | 2.608B |
| December 31, 2022 | 2.520B |
| September 30, 2022 | 2.456B |
| June 30, 2022 | 2.323B |
| March 31, 2022 | 2.155B |
| December 31, 2021 | 2.128B |
| September 30, 2021 | 2.073B |
| June 30, 2021 | 2.032B |
| March 31, 2021 | 2.011B |
| December 31, 2020 | 1.955B |
| September 30, 2020 | 1.780B |
| June 30, 2020 | 1.731B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.704B |
| December 31, 2019 | 1.679B |
| September 30, 2019 | 1.710B |
| June 30, 2019 | 1.662B |
| March 31, 2019 | 1.628B |
| December 31, 2018 | 1.568B |
| September 30, 2018 | 1.523B |
| June 30, 2018 | 1.460B |
| March 31, 2018 | 1.389B |
| December 31, 2017 | 1.356B |
| September 30, 2017 | 1.335B |
| June 30, 2017 | 1.325B |
| March 31, 2017 | 1.316B |
| December 31, 2016 | 1.281B |
| September 30, 2016 | 1.237B |
| June 30, 2016 | 1.200B |
| March 31, 2016 | 1.158B |
| December 31, 2015 | 1.124B |
| September 30, 2015 | 1.098B |
| June 30, 2015 | 1.061B |
| March 31, 2015 | 1.000B |
| December 31, 2014 | 928.87M |
| September 30, 2014 | 851.12M |
| June 30, 2014 | 790.51M |
| March 31, 2014 | 726.59M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Avadel Pharmaceuticals Plc | 234.76M |
| Perrigo Co. Plc | 1.381B |
| GH Research Plc | -0.359M |
| Cosmo NV | 54.51M |
| Axsome Therapeutics, Inc. | 714.10M |